Ad is loading...
CNTX
Price
$1.84
Change
-$0.06 (-3.16%)
Updated
Nov 15 closing price
121 days until earnings call
DSGN
Price
$5.80
Change
-$0.22 (-3.65%)
Updated
Nov 15 closing price
108 days until earnings call
Ad is loading...

CNTX vs DSGN

Header iconCNTX vs DSGN Comparison
Open Charts CNTX vs DSGNBanner chart's image
Context Therapeutics
Price$1.84
Change-$0.06 (-3.16%)
Volume$133.35K
CapitalizationN/A
Design Therapeutics
Price$5.80
Change-$0.22 (-3.65%)
Volume$240.52K
CapitalizationN/A
CNTX vs DSGN Comparison Chart
Loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CNTX vs. DSGN commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a StrongSell and DSGN is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CNTX: $1.84 vs. DSGN: $5.80)
Brand notoriety: CNTX and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 43% vs. DSGN: 125%
Market capitalization -- CNTX: $138M vs. DSGN: $328.4M
CNTX [@Biotechnology] is valued at $138M. DSGN’s [@Biotechnology] market capitalization is $328.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTX is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 4 TA indicator(s) are bullish while DSGN’s TA Score has 6 bullish TA indicator(s).

  • CNTX’s TA Score: 4 bullish, 5 bearish.
  • DSGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than CNTX.

Price Growth

CNTX (@Biotechnology) experienced а -5.64% price change this week, while DSGN (@Biotechnology) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

CNTX is expected to report earnings on Mar 19, 2025.

DSGN is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($328M) has a higher market cap than CNTX($138M). DSGN YTD gains are higher at: 118.868 vs. CNTX (62.832). CNTX has higher annual earnings (EBITDA): -20.01M vs. DSGN (-62.82M). DSGN has more cash in the bank: 261M vs. CNTX (102M). CNTX (0) and DSGN (0) have equivalent revenues.
CNTXDSGNCNTX / DSGN
Capitalization138M328M42%
EBITDA-20.01M-62.82M32%
Gain YTD62.832118.86853%
P/E RatioN/AN/A-
Revenue00-
Total Cash102M261M39%
Total DebtN/A2.7M-
TECHNICAL ANALYSIS
Technical Analysis
CNTXDSGN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TQEZX8.96N/A
N/A
AMG TimesSquare Emerging Mkts Sm Cp Z
FRVFX51.55-0.41
-0.79%
Franklin Small Cap Value C
VVERX8.75-0.07
-0.79%
Virtus Ceredex Small-Cap Value Eq R6
MINVX31.26-0.31
-0.98%
Madison Investors Y
IMIDX26.32-0.42
-1.57%
Congress Mid Cap Growth Institutional

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and FATE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-3.16%
FATE - CNTX
30%
Poorly correlated
-2.88%
DSGN - CNTX
29%
Poorly correlated
-3.65%
CMMB - CNTX
29%
Poorly correlated
-3.74%
HRMY - CNTX
27%
Poorly correlated
+0.65%
TYRA - CNTX
25%
Poorly correlated
-5.81%
More

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with CYTK. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-3.65%
CYTK - DSGN
39%
Loosely correlated
-8.19%
MDGL - DSGN
38%
Loosely correlated
-4.66%
AGIO - DSGN
36%
Loosely correlated
-2.92%
RCKT - DSGN
36%
Loosely correlated
-5.67%
TERN - DSGN
34%
Loosely correlated
-5.80%
More